Literature DB >> 31843967

Survival of Streptococcus suis in Porcine Blood Is Limited by the Antibody- and Complement-Dependent Oxidative Burst Response of Granulocytes.

Viktoria Rungelrath1, Sophie Öhlmann1, Gottfried Alber2, Wieland Schrödl1, Maren von Köckritz-Blickwede3,4, Nicole de Buhr3,4, Alexander Martens3,4, Christoph Georg Baums5, Nicole Schütze2.   

Abstract

Bacteremia is a hallmark of invasive Streptococcus suis infections of pigs, often leading to septicemia, meningitis, or arthritis. An important defense mechanism of neutrophils is the generation of reactive oxygen species (ROS). In this study, we report high levels of ROS production by blood granulocytes after intravenous infection of a pig with high levels of S. suis-specific antibodies and comparatively low levels of bacteremia. This prompted us to investigate the working hypothesis that the immunoglobulin-mediated oxidative burst contributes to the killing of S. suis in porcine blood. Several S. suis strains representing serotypes 2, 7, and 9 proved to be highly susceptible to the oxidative burst intermediate hydrogen peroxide, already at concentrations of 0.001%. The induction of ROS in granulocytes in ex vivo-infected reconstituted blood showed an association with pathogen-specific antibody levels. Importantly, inhibition of ROS production by the NADPH oxidase inhibitor apocynin led to significantly increased bacterial survival in the presence of high specific antibody levels. The oxidative burst rate of granulocytes partially depended on complement activation, as shown by specific inhibition. Furthermore, treatment of IgG-depleted serum with a specific IgM protease or heat to inactivate complement resulted in >3-fold decreased oxidative burst activity and increased bacterial survival in reconstituted porcine blood in accordance with an IgM-complement-oxidative burst axis. In conclusion, this study highlights an important control mechanism of S. suis bacteremia in the natural host: the induction of ROS in blood granulocytes via specific immunoglobulins such as IgM.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  IgM; NADPH oxidase; Streptococcus suiszzm321990; complement; neutrophil; oxidative burst; reactive oxygen species; respiratory burst

Mesh:

Substances:

Year:  2020        PMID: 31843967      PMCID: PMC7035923          DOI: 10.1128/IAI.00598-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  The role of complement in the acquired immune response.

Authors:  C H Nielsen; E M Fischer; R G Leslie
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

2.  Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases.

Authors:  E Caron; A Hall
Journal:  Science       Date:  1998-11-27       Impact factor: 47.728

3.  Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivo.

Authors:  Kevin Fabrizio; Catherine Manix; Allan J Guimaraes; Joshua D Nosanchuk; Liise-Anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2010-03-03

4.  Inactivation of the sodA gene of Streptococcus suis type 2 encoding superoxide dismutase leads to reduced virulence to mice.

Authors:  Yulong Tang; Xiaoyan Zhang; Wei Wu; Zhongyan Lu; Weihuan Fang
Journal:  Vet Microbiol       Date:  2012-02-28       Impact factor: 3.293

Review 5.  Critical Streptococcus suis Virulence Factors: Are They All Really Critical?

Authors:  Mariela Segura; Nahuel Fittipaldi; Cynthia Calzas; Marcelo Gottschalk
Journal:  Trends Microbiol       Date:  2017-03-06       Impact factor: 17.079

6.  Critical role for complement receptor 3 (CD11b/CD18), but not for Fc receptors, in killing of Streptococcus pyogenes by neutrophils in human immune serum.

Authors:  Maria Nilsson; Maria Weineisen; Tommy Andersson; Lennart Truedsson; Ulf Sjöbring
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

7.  Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.

Authors:  H E Smith; M Damman; J van der Velde; F Wagenaar; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

8.  Elicitor-stimulated ion fluxes and O2- from the oxidative burst are essential components in triggering defense gene activation and phytoalexin synthesis in parsley.

Authors:  T Jabs; M Tschope; C Colling; K Hahlbrock; D Scheel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Identification of a novel host-specific IgM protease in Streptococcus suis.

Authors:  Jana Seele; Alena Singpiel; Christian Spoerry; Ulrich von Pawel-Rammingen; Peter Valentin-Weigand; Christoph G Baums
Journal:  J Bacteriol       Date:  2012-12-14       Impact factor: 3.490

10.  Neutrophil extracellular trap formation in the Streptococcus suis-infected cerebrospinal fluid compartment.

Authors:  Nicole de Buhr; Friederike Reuner; Ariane Neumann; Carolin Stump-Guthier; Tobias Tenenbaum; Horst Schroten; Hiroshi Ishikawa; Kristin Müller; Andreas Beineke; Isabel Hennig-Pauka; Thomas Gutsmann; Peter Valentin-Weigand; Christoph G Baums; Maren von Köckritz-Blickwede
Journal:  Cell Microbiol       Date:  2016-08-31       Impact factor: 3.715

View more
  2 in total

1.  d-Alanylation of Lipoteichoic Acids in Streptococcus suis Reduces Association With Leukocytes in Porcine Blood.

Authors:  Sophie Öhlmann; Ann-Kathrin Krieger; Nicolas Gisch; Marita Meurer; Nicole de Buhr; Maren von Köckritz-Blickwede; Nicole Schütze; Christoph Georg Baums
Journal:  Front Microbiol       Date:  2022-04-18       Impact factor: 6.064

Review 2.  A critical review speculating on the protective efficacies of autogenous Streptococcus suis bacterins as used in Europe.

Authors:  Karoline Rieckmann; Sophia-Mareike Pendzialek; Thomas Vahlenkamp; Christoph G Baums
Journal:  Porcine Health Manag       Date:  2020-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.